Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison

Documenti analoghi

• Is Docetaxel Essential for Darolutamide‐Based Metastatic Hormone‐Sensitive Prostate Cancer Therapy?
  di: Wei Chen, et al.
  Pubblicazione: (2025)
• Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin‐Induced Ferroptosis in Liver Cancer
  di: Bin Zhang, et al.
  Pubblicazione: (2025)
• MITF Gain‐of‐Function Mutation in Metastatic Prostate Cancer: A Rare Finding With Potential Therapeutic Significance
  di: Paul J. Pecorin, et al.
  Pubblicazione: (2026)
• Hormone Receptor‐Dependent Correlations Between Angiopoietins and VEGF ‐C in Primary Breast Cancer: Insights Into Lymphangiogenic Biomarkers
  di: Vahid Montazeri, et al.
  Pubblicazione: (2025)
• Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
  di: Kazuro Kikkawa, et al.
  Pubblicazione: (2024)